Regency Centers Corporation
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: REG stock price vs ACN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ACN's multiple
Needs Annual EPS, ACN P/E.
Implied fair value · at REG's multiple
Needs REG P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
REGENCY CENTERS CORPORATION · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Accenture plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
KIMCO REALTY CORP
REG vs KIM
Brixmor Property Group Inc.
REG vs BRX
AGREE REALTY CORP
REG vs ADC
CROWN CASTLE INC.
REG vs CCI
REALTY INCOME CORP
REG vs O
INTERNATIONAL BUSINESS MACHINES CORP
REG vs IBM
COGNIZANT TECHNOLOGY SOLUTIONS CORP
REG vs CTSH
DXC Technology Co
REG vs DXC
Infosys Ltd
REG vs INFY
MARSH & MCLENNAN COMPANIES, INC.
REG vs MMC
ROBERT HALF INC.
REG vs RHI
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe REG’s premium valuation is justified by durable REIT-quality margins and that its price should stay near its historical band rather than converge to ACN’s lower multiple, then holding rather than selling makes sense because ACN-implied downside is driven mainly by multiple compression, not by clear operational weakness.
REG trades at $82.09 versus an implied price of $33.43 on ACN P/E basis, a -59.3% downside that reflects a much richer multiple than ACN. However, REG also sits inside its own historical band of $73.88 to $90.30, which tempers the bearishness of ACN comparison.
Supporting Metrics